Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Christoph Correll, MD
Advertisement
Christoph Correll, MD, is a clinical professor of psychiatry at the Zucker School of Medicine at Hofstra/Northwell.
Articles by Christoph Correll, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Patient Care Online
1
Menopause Care in Primary Care: Closing Diagnosis and Treatment Gaps
2
Primary Care Lens: Atrial Fibrillation From Detection to Referral in Primary Care
3
Night Sweats in Midlife Women: A Q&A With Cheryl Cox Kinney, MD
4
Elinzanetant Reduced Menopausal VMS Frequency by ≥50% in 67% of Women at Week 12: TMS 2026
5